At Diopsys, Inc., we are dedicated to developing breakthrough technology and encouraging both innovative thinking and a creative pioneering spirit to provide medically necessary electrophysiological testing. The Diopsys management team has significant engineering, management, operations, marketing and sales experience in medical instrumentation and related fields.

Since January 2000, the Diopsys management team has been led by Joseph Fontanetta. Mr. Fontanetta has served as the company’s President and Chief Executive Officer and as a member of the Board of Directors during that period. In addition, he has 30 years senior management experience in health care including: Chief Operating Officer at Lawrence Hospital, and Executive Vice President & COO for Franciscan Health Systems. Mr. Fontanetta has also held senior sales and marketing positions at Fortune 500 medical industry companies including: Corning Glass, Bristol-Myers Squibb and Eli Lilly.

In addition to the highly qualified and seasoned group of professionals at Diopsys, the company is fortunate to have the assistance of knowledgeable and highly respected members of the scientific and medical community to help guide the development and implementation of the company’s sophisticated medical devices.

Scientific Advisory Board

Alberto González García, M.D.
Chairman of the Diopsys Scientific Advisory Board
Research Director, Diopsys

Dr. González received his medical training at Finlay-Albarran in Havana, Cuba. He completed fellowships in Neuro-Ophthalmology at the National Institute of Neurology and Neurosurgery in Cuba, and in Glaucoma at the Hamilton Glaucoma Center at the University of California San Diego. He was Chief of the Neuro-Ophthalmology Department at the National Institute of Neurology and Neurosurgery and a clinician and surgeon at the National Institute of Ophthalmology in Cuba. He has published and contributed to numerous books and studies in the areas of early diagnosis of glaucoma, ischemic optic neuropathy, and optic coherence tomography (OCT) in the diagnosis of retina and optic nerve diseases, among many others.

David Brown, M.D., FAAP
Senior Pediatrician/Neonatologist, Children’s Medical Group
Active Attending Staff, Connecticut Children’s Medical College
Senior Attending Staff, Hartford Hospital
American Academy of Pediatrics, Member/Fellow

Dr. Brown, a pediatrician at the Children’s Medical Group in Bloomfield, CT., was the first medical director for pediatric research trials for the Physicians Research Network and is a current member of the founding committee. He has been a member of the American Board of Pediatrics for 30 years and is a seasoned pediatrician, available to discuss the importance of the Enfant® and the need to check children’s vision early in order to prevent severe vision problems later in life.

John B. Siegfried, Ph.D.
Professor of Physiological Optics, Pennsylvania College of Optometry
Adjunct Professor, Dept of Ophthalmology, University of Medicine and Dentistry, NJ
Association for Research in Vision and Ophthalmology, Member
International Society for Clinical Electrophysiology of Vision, Member

Dr. Siegfried, an expert in the field of optometry for nearly 40 years, has spent a good portion of his career teaching various subjects from psychology and biophysics to physiological optics. It is this widespread knowledge as a teacher and researcher, as well as his many published works, that enhance his VEP expertise.

John Simon, M.D.
Chief of Pediatric Ophthalmology, Lions Eye Institute of Albany Medical Center
Chairman, Dept of Ophthalmology, Albany Medical College
Director of Pediatric Ophthalmology and Strabismus Service, Albany Medical College
Professor of Ophthalmology and Pediatrics, Albany Medical College

Dr. Simon is a noted expert in the fields of ophthalmology and pediatrics and was one of five investigators to conduct the Phase IV clinical trials of the Enfant® Pediatric Vision Testing System.